This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Saxen E. Histopathology in cancer epidemiology. In: Sommers SC, Rosen PR (eds) Pathology Annual, Pt. 1. New York: Appleton, Century and Crofts, 1979, pp. 203–17.
Eustis SL. The sequential development of cancer: a morphological perspective. Toxicol Lett 1989; 49:267–81.
Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumors. Nature 2000; 406:747–57.
Fend F, Raffeld M. Laser capture microdissection in pathology. J Clin Pathol 2000; 53:666–72.
Kandel R, Li SQ, Ozcelik H, et al. p53 protein accumulation and mutations in normal and benign breast tissue. Int J Cancer 2000; 87:73–8.
Westra WH, Sidransky D. Phenotypic and genotypic disparity in premalignant lesions: of calm water and crocodiles. J Natl Cancer Inst 1998; 90:1500–1.
Rohan TE, Hartwick W, Miller AB, et al. Immunohistochemical detection of c-erbB-2 and p53 in benign breast disease and breast cancer risk. J Natl Cancer Inst 1998; 90:1262–9.
Gobbi H, Dupoint WD, Simpson JF, et al. Transforming growth factor-b and breast cancer risk in women with mammary epithelial hyperplasia. J Natl Cancer Inst 1999; 91:2096–101.
Ahrendt SA, Sidransky D. The potential of molecular screening. Surg Oncol Clin N Am 1999; 8:641–56.
Lippman SM, Lee JJ, Sabichi AL. Cancer chemoprevention: progress and promise. J Natl Cancer Inst 1998; 90:1514–28.
Pinsky PF. A multi-stage model of adenoma development. J Theor Biol 2000; 207:129–43.
Myers ER, McCrory DC, Nanda K, et al. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 2000; 151:1158–71.
Franco EL. The sexually-transmitted disease model for cervical cancer: Incoherent epidemiologic findings and the role of misclassification of human papillomavirus infection. Epidemiology 1991; 2:98–106.
Makni H, Franco E, Kaiano J, et al. P53 polymorphism in codon 72 and risk of HPV-induced cervical cancer: effect of inter-laboratory variation. Int J Cancer 2000; 87:528–33.
Freedman LS, Graubard BI, Schatzkin A. Statistical validation of intermediate endpoints for chronic diseases. Stat Med 1992; 11:167–78.
Buyse M, Molenberghs G. Criteria for the validation of surrogate endpoints in randomized experiments. Biometrics 1998; 54:1014–29.
McMichael AJ. Invited commentary—“Molecular epidemiology”: new pathway or new traveling companion? Am J Epidemiol 1994; 140:1–11.
Zur Hausen H. Cervical carcinoma and human papillomavirus: On the road to preventing a major human cancer. J Natl Cancer Inst 2001; 93:252–3.
Guha U, Hulit J, Pestell RG. Transgenic mice in cancer research. In: Bertino J (ed) Encyclopedia of cancer, 2nd ed. New York: Academic Press, 2001, (in press).
Wang TC, Cardiff RD, Zukerberg L, et al. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 1994; 369:669–71.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Rohan, T.E., Franco, E.L. (2002). Prospects. In: Franco, E.L., Rohan, T.E. (eds) Cancer Precursors. Springer, New York, NY. https://doi.org/10.1007/0-387-21605-7_26
Download citation
DOI: https://doi.org/10.1007/0-387-21605-7_26
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-95188-1
Online ISBN: 978-0-387-21605-8
eBook Packages: Springer Book Archive